Using gene sequencing to improve cancer care
Part of Cancer clinical trials.
This study looks at how well a special type of gene testing (called sequencing) works for people with cancer. It aims to learn if this test helps doctors choose better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with cancer.
- You must have been referred for advanced gene testing, like sequencing your whole genome.
- The decision to do this testing must have been approved by a team of cancer experts since January 1, 2021.
- You must agree to allow your medical and gene information to be used for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at stored tumor samples to understand why some people respond much better or much worse than expected. The goal is to learn what the tumor’s genes might be telling doctors about response to treatment.
This study looks at whole genome sequencing (a complete read of your DNA) from children and young people with cancer. It aims to learn more about cancer and how it might be treated.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This real-world study follows adults in Canada who have cancer that was tested and found to have rare molecular (DNA/protein) changes. It helps researchers understand how these rare findings show up and how care happens in everyday practice.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This study uses advanced DNA sequencing to figure out unclear or unusual blood (hematologic) conditions when standard tests are not enough. It may help your care team reach a more accurate diagnosis by better understanding what’s driving your illness.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.